OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001091326

BIOMOLECULAR LIFE HOLDINGS, INC. (BIOM)

BIOMOLECULAR LIFE HOLDINGS, INC. (CIK 0001091326, ticker BIOM, EIN 33-0814123) reported revenue of $0 for FY2014 (2014-01-01 to 2014-12-31) and net income of -$6.19 million (-$6,189,504) for FY2014 (2014-01-01 to 2014-12-31), as filed in its 10-K filed 2015-04-15 (accession 0001019687-15-001463).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001091326
TickersBIOM (OTC)
EIN33-0814123
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categorySmaller reporting company
Entity typeoperating
Olympus entity IDorg_72s6nqwdhkbz7m2xjpnm64rv0n
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20142014-01-01 to 2014-12-3110-K2015-04-150001019687-15-001463Revenues
Net income-$6,189,504FY20142014-01-01 to 2014-12-3110-K2015-04-150001019687-15-001463NetIncomeLoss
Total assets$1,323,102FY2014as of 2014-12-3110-K2015-04-150001019687-15-001463Assets
Stockholders' equity-$4,506,020FY2014as of 2014-12-3110-K2015-04-150001019687-15-001463StockholdersEquity
Operating cash flow-$1,909,459FY20142014-01-01 to 2014-12-3110-K2015-04-150001019687-15-001463NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Diluted earnings per share-$0.22 per shareFY20142014-01-01 to 2014-12-3110-K2015-04-150001019687-15-001463EarningsPerShareBasicAndDiluted
Shares outstanding61,584,929 sharesFY2014as of 2015-04-1010-K2015-04-150001019687-15-001463EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2005-2014, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20142014-01-01 to 2014-12-31$010-K2015-04-150001019687-15-001463
Net incomeFY20142014-01-01 to 2014-12-31-$6,189,50410-K2015-04-150001019687-15-001463

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2015-11-192015-09-300001019687-15-004252vglife_10q-093015.htm
10-Q2015-08-192015-06-300001019687-15-003202vglife_10q-063015.htm
10-Q2015-05-202015-03-310001019687-15-002045vglife_10q-033115.htm
10-K2015-04-152014-12-310001019687-15-001463vgls_10k-123114.htm
10-Q2014-11-132014-09-300001019687-14-004238vglife_10q-093014.htm
10-K2001-08-282001-05-310001052918-01-500082fivestar10kmay31.txt
10-Q2001-04-132001-02-280001052918-01-0000740001.txt
10-Q2001-01-162000-11-300001052918-01-0000160001.txt
10-Q2000-10-132000-08-310001091326-00-0000170001.txt
10-K2000-08-292000-05-310001091326-00-0000150001.txt
10-Q2000-04-102000-02-290001091326-00-000004—
10-Q2000-01-261999-11-300000897101-00-000051—

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001091326published by the sourcedata.sec.gov/submissions/CIK0001091326.json2026-10-21
Employer Identification Number (EIN) · US-EIN33-0814123published by the sourcedata.sec.gov/submissions/CIK0001091326.json2026-10-21

Former names

NameFromTo
SB Technology Holdings, Inc.2026-05-042026-05-04
VG Life Sciences Inc.2014-11-132026-03-06
VG Life Sciences, Inc.2014-06-202014-10-14
VIRAL GENETICS INC /DE/2002-04-012009-03-25
5 STARLIVING ONLINE INC1999-07-292001-10-18

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001091326.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001091326.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001091326" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001091326/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001091326/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1091326"}

On SEC EDGAR

About this data